Invention Grant
- Patent Title: Heterocyclic compound
-
Application No.: US14566157Application Date: 2014-12-10
-
Publication No.: US09388195B2Publication Date: 2016-07-12
- Inventor: Misaki Homma , Toru Miyazaki , Yuya Oguro , Osamu Kurasawa
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Hamre, Schumann, Mueller & Larson, P.C.
- Priority: JP2010-031899 20100217; JP2010-131950 20100609
- Main IPC: C07D495/04
- IPC: C07D495/04 ; C07D498/20
Abstract:
Provided is a compound useful for the prophylaxis or treatment of cancer.The present invention relates to a compound represented by formula (I): wherein each symbol in the formula is as defined in the specification, or a salt thereof or a prodrug thereof, which is useful for the prophylaxis or treatment of cancer.
Public/Granted literature
- US20150158882A1 HETEROCYCLIC COMPOUND Public/Granted day:2015-06-11
Information query
